Clinical Trial Update: A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial named XMaS is evaluating xanthohumol metabolism and signature in Crohn's disease. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Xanthohumol (Xanthohumol)

Snippet

Sponsor: National University of Natural Medicine | Conditions: Crohn Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING